Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Craig Rogers who wrote (7624)	5/1/1998 11:40:00 PM
From: DR.TECH	Respond to of 23519

WAKE UP CALL FOR SHORTS LOOK AT 1999 ESTIMATES. IF YOU ...truly feel viagra will be the only successful ED treatment stay short. I CAN TELL YOU the analyst 1999 estimates are saying muse can successfully co-exist as an alternative....We won't see any sign of that with monday's #'s. Viagra is still in the honeymoon stage. And as I said before, the C/R analyst had guts to say it during viagra's intro. However, did you know that PW analyst has higher eps est than the C/R analyst for both 98 and 99 for vvus. If this companies eps was coming from 0 with out all the B.S. it would be trading at 30 to 40 a share since most analyst are showing 100+ % growth from 98 to 99. The only question I have is who pulls the trigger first...the analyst or the shorts. Either way I want to be around when vvus supporters or detractors figure out that #2 in a few billion dollar market is great$$$$$. When that happens 100% pop in one week and it will be just for starters.